| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_108e14acad7aeb5b5f02b6b5f6d69557
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0128b1ea25bace77f9ff5dc6b2210d7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_3fdca10276e46f0dcfe4514070b1cdab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9d0211f0389012f93500bb14c51decd9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c57a84e8add1dc2939e8c18da4846c3d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7c867ee8a2dcdafabaab6c15bd47768b |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2740-16222
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2500-02 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56988
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-005 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 |
| filingDate |
2003-01-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6915df3f38dc19a32a153e997304a785
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f8973b7f47970c5ab2779f17d96bba75
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cf32f32e4ebf49bd669932f499fc2f98
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ba94164952af2fa9700d90852913c715
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19e9ea7b004f9de808899a367c1f7dd9 |
| publicationDate |
2003-07-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-03060098-A2 |
| titleOfInvention |
Methods for identifying compounds which inhibit binding of nucleocapsid 7 protein to hiv-1 rna |
| abstract |
The present invention relates to methods of identifying a molecule from a library of molecules that inhibits binding of human immunodeficiency virus nucleocapsid 7 polypeptide (NCp7) to an oligonucleotide which comprises admixing an NCp7 polypeptide with at one labeled HIV-1 psi-site oligonucleotide and an amount of the molecule to be tested under binding conditions; and determining the amount of oligonucleotide bound to the NCp7 polypeptide, wherein a decrease in the amount of oligonucleotide bound in the presence of the molecule compared with the amount of oligonucleotide bound in the absence of the molecule indicates that the molecule inhibits binding of NCp7 polypeptide to the oligonucleotide. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103172587-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1425262-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104854085-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-110139870-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107677811-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103172587-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-103169700-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2014090913-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-11208433-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106198962-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10239831-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-7528274-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2015537053-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1425262-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8076372-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2898903-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-107677811-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2213299-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-3556766-A4
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106198962-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-10053421-B2 |
| priorityDate |
2002-01-11-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |